
Australia's SpeeDx raises $15m from US-based Northpond

SpeeDx, an Australian developer of molecular diagnostics solutions, has raised $15 million from US-based VC firm Northpond Ventures across two tranches.
Founded in 2009, SpeeDx focuses on in vitro diagnostic tests involving molecules that bind to certain chemicals, creating radiological markers that allow for the detection of diseases in real time. Its...
Latest News
China AI drug discovery platform StoneWise raises $100m
StoneWise, a Chinese biotech start-up that uses artificial intelligence (AI) technology to develop new drugs, has raised $100 million in Series B funding across two tranches.
Media SPAC legitimizes MENA for Asia investors
The imminent US listing of a Middle East and North Africa (MENA) media app via a special purpose acquisition company (SPAC) is helping legitimize the region for Asian private equity.
Australia's Quadrant loses growth fund head
Justin Ryan, a managing partner at Quadrant Private Equity and latterly head of the Australian firm’s growth strategy, is stepping back from day-to-day investment activity.
KKR joins $61m round for Japan's Netstars
KKR has contributed JPY4 billion ($37 million) to a JPY6.6 billion funding round for Netstars, a Japanese QR code payment gateway operator. SIG and Lun Partners, a Hong Kong-based global financial technology investor, also took part.